Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
6.20
+0.04 (0.57%)
Jan 16, 2026, 10:19 AM EST - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $923.4 million as of January 16, 2026. Its market cap has increased by 66.91% in one year.
Market Cap
923.40M
Enterprise Value
759.38M
1-Year Change
66.91%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $923.40M, an increase of 44.39%. That is a compound annual growth rate of 6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 995.69M | 33.07% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |